DNA isolated from blood spiked with live spirochetes, with or without culture in BSKII + RS medium, was used as template for real-time PCR for recA amplicon of B. burgdorferi (Figure 8A
and 8B). Detection of spirochete DNA did not significantly improve after culture when the number was close to 1 per 1.5 ml of blood. The presence of 10 spirochetes in 1.5 ml of blood could be consistently detected albeit without accurate quantification irrespective of blood culture (data not shown). Bioactive Compound Library cell line quantitation www.selleckchem.com/products/sn-38.html of 100 spirochetes in 1.5 ml of blood or 100 μl of total DNA isolated from spiked blood (i.e. 5 spirochetes per 5 μl of template used in PCR) was accurate and consistent both with and without culture in BSKII + RS. Thus, the sensitivity of detection in this assay remains better than in any other nucleic acids based assays for Lyme spirochetes described previously. Selleckchem Lazertinib Figure 8 Multiplex assay using 1.5 ml human blood spiked with serial dilutions of Lyme spirochetes can recover and quantitate B. burgdorferi . (A) B. burgdorferi were detected consistently in all replicates when ≥5 bacteria were present per ~75 μl of blood, i.e., when 5 μl of total 100 μl DNA recovered from 1.5 ml spiked blood was isolated without additional manipulation. Detection of human
Actin A1 was not affected in the multiplex assay, as expected (data not shown). (B) Improvement in recovery and quantitation of B. burgdorferi after 48 h culture of Lyme spirochetes spiked human blood in BSKII + RS medium at 33°C was not significant. Discussion Lyme disease is prevalent in both the Unites
States and Europe. Although B. burgdorferi sensu stricto is documented to be the spirochete responsible for Lyme disease in the USA, B. afzelii and B. garinii affect a significant population in Europe and Asian countries [67, 68]. Emerging pathogenic disease anaplasmosis caused by A. phagocytophilum is one of the most prevalent life-threatening tick-borne diseases and has recently become notifiable in the United States [14, 69]. Furthermore, B. microti in the USA and B. divergens in Europe have become important tick-borne parasitic diseases and infections with these pathogens are increasing steadily [10, 70]. Another Amine dehydrogenase major upcoming problem is blood transfusion associated babesiosis that can remain undetected and result in fatalities, and thus, is becoming a blood safety threat [71–74]. Serological tests used for diagnosis of Lyme disease, anaplasmosis and babesiosis cannot be used early in infection before the adaptive immune response is established. In addition, due to persisting antibodies long after disease has resolved and patient is cured, these tests cannot be used to detect active infection and they fail as test of cure. These difficulties add to the disadvantage of using the indirect serological diagnostic tests for tick-borne infectious diseases.